Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVKDIAL: VKA vs No Anticoagulation in Hemodialysis with AF
NCT02886962Phase 4Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Jul 2017
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Cumulative incidence of severe bleedings and thrombosis at 2 years. Started Jul 2017; status: terminated.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02886962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02886962.